Synopsis
Synopsis
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. L-methadone Hydrochloride
2. L-polamidon Hydrochloride
3. 5967-73-7
4. L-6-dimethylamino-4,4-diphenyl-3-heptanone Hydrochloride
5. V57lc776c0
6. L-amidone Hydrochloride
7. L-dolophine Hydrochloride
8. Methadone Hydrochloride, L-
9. (-)-methadone Hydrochloride
10. Methadone Hydrochloride L-form
11. Methadone Hcl L-form
12. Einecs 227-756-6
13. Unii-v57lc776c0
14. Levomethadone Hcl
15. (r)-dimethyl(1-methyl-4-oxo-3,3-diphenylhexyl)ammonium Chloride
16. 1,1-diphenyl-1-(2-dimethylaminopropyl)-2-butanone
17. L-polamidon (tn)
18. 3-heptanone, 6-(dimethylamino)-4,4-diphenyl-, Hydrochloride, (r)-
19. 3-heptanone, 6-(dimethylamino)-4,4-diphenyl-, Hydrochloride, (-)-
20. Schembl396161
21. Dtxsid30975070
22. (6r)-6-(dimethylamino)-4,4-diphenylheptan-3-one Hydrochloride
23. Methadone L-form Hydrochloride
24. D-(-)-methadone Hydrochloride
25. Levomethadone Hydrochloride [mart.]
26. Levomethadone Hydrochloride [who-dd]
27. Methadone L-form Hydrochloride [mi]
28. D08122
29. Levomethadone Hydrochloride [ep Monograph]
30. Q27291550
31. (6r)-6-(dimethylamino)-4,4-diphenylheptan-3-one;hydrochloride
32. 6-(dimethylamino)-4,4-diphenylheptan-3-one--hydrogen Chloride (1/1)
33. 3-heptanone, 6-(dimethylamino)-4,4-diphenyl-, Hydrochloride (1:1), (6r)-
Molecular Weight | 345.9 g/mol |
---|---|
Molecular Formula | C21H28ClNO |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 7 |
Exact Mass | 345.1859422 g/mol |
Monoisotopic Mass | 345.1859422 g/mol |
Topological Polar Surface Area | 20.3 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 346 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Levomethadone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levomethadone, including repackagers and relabelers. The FDA regulates Levomethadone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levomethadone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levomethadone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levomethadone supplier is an individual or a company that provides Levomethadone active pharmaceutical ingredient (API) or Levomethadone finished formulations upon request. The Levomethadone suppliers may include Levomethadone API manufacturers, exporters, distributors and traders.
click here to find a list of Levomethadone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Levomethadone DMF (Drug Master File) is a document detailing the whole manufacturing process of Levomethadone active pharmaceutical ingredient (API) in detail. Different forms of Levomethadone DMFs exist exist since differing nations have different regulations, such as Levomethadone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Levomethadone DMF submitted to regulatory agencies in the US is known as a USDMF. Levomethadone USDMF includes data on Levomethadone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Levomethadone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Levomethadone suppliers with USDMF on PharmaCompass.
A Levomethadone CEP of the European Pharmacopoeia monograph is often referred to as a Levomethadone Certificate of Suitability (COS). The purpose of a Levomethadone CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Levomethadone EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Levomethadone to their clients by showing that a Levomethadone CEP has been issued for it. The manufacturer submits a Levomethadone CEP (COS) as part of the market authorization procedure, and it takes on the role of a Levomethadone CEP holder for the record. Additionally, the data presented in the Levomethadone CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Levomethadone DMF.
A Levomethadone CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Levomethadone CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Levomethadone suppliers with CEP (COS) on PharmaCompass.
A Levomethadone written confirmation (Levomethadone WC) is an official document issued by a regulatory agency to a Levomethadone manufacturer, verifying that the manufacturing facility of a Levomethadone active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Levomethadone APIs or Levomethadone finished pharmaceutical products to another nation, regulatory agencies frequently require a Levomethadone WC (written confirmation) as part of the regulatory process.
click here to find a list of Levomethadone suppliers with Written Confirmation (WC) on PharmaCompass.
Levomethadone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levomethadone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levomethadone GMP manufacturer or Levomethadone GMP API supplier for your needs.
A Levomethadone CoA (Certificate of Analysis) is a formal document that attests to Levomethadone's compliance with Levomethadone specifications and serves as a tool for batch-level quality control.
Levomethadone CoA mostly includes findings from lab analyses of a specific batch. For each Levomethadone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levomethadone may be tested according to a variety of international standards, such as European Pharmacopoeia (Levomethadone EP), Levomethadone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levomethadone USP).
LOOKING FOR A SUPPLIER?